/NOT FOR DISSEMINATION IN THE UNITED STATES OF FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES/
LACHENAIE, QC, May 20 /CNW Telbec/ - Capital Pro-Égaux Inc. (the "Company") reports that its wholly owned subsidiary SINLAB Inc, has concluded an agreement with its current exclusive distributor BIOMET/3i to amend its current license in the following manner as of May 20th of 2010:
- Amendment of the term of the Agreement to the end of the patents
life of 2017.
- Amendment of current exclusive license to a non exclusive
manufacturing, marketing, sales and distribution license thus,
providing SINLAB Inc with the sole and exclusive right to bring
suit in its own name and to grant other non-exclusive licenses.
- Amendment of the current royalty structure based on volume of sales
and payment structure of quarterly installments to a lump sum
amount payable partly at the effective date of the amended license
followed by two subsequent payments at month 12 and 24 of the
- Abolition of "transfer of interest in SINLAB Inc" clause whereby
SINLAB inc will not have, in the eventuality of the reception of an
offer to purchase by a third party, the obligation to submit offer
to BIOMET/3i for considerations.
- All other clauses of the previous license remain in force in the
About Pro-Égaux Inc.
Pro-Égaux through its wholly owned subsidiary, SINLAB Inc, is a company based in Lachenaie, Quebec, specializing mainly in the conception and design of titanium products to be used in the dental prosthesis restoration industry. The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.
SOURCE Capital Pro-Égaux Inc.
For further information: For further information: Pierre Désormeau, President, Capital Pro-Égaux Inc., (514) 616-0612, Fax: (450) 226-1923, firstname.lastname@example.org